Skip to main content
. Author manuscript; available in PMC: 2019 May 23.
Published in final edited form as: Biochem Biophys Res Commun. 2018 Apr 9;499(4):751–757. doi: 10.1016/j.bbrc.2018.03.209

Fig.3. Cambinol decreases nSMase2 activity in mouse brain extracts.

Fig.3

C57BL6 mice were treated with 100 mg/kg of cambinol or vehicle (DMSO) by oral gavage and sacrificed 4 hours after the treatment (2 mice per group). (A) Drug concentration in plasma (black column) and brain tissue (grey column) from cambinol treated animals (mean±SEM). (B) nSMase2 activity in the brain homogenates after cambinol- treatment compared to vehicle.